You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Group B Streptococcal

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Invasive Group B Streptococcus Disease Burden and Its

Recruiting
  • Invasive Infection
  • +3 more
  • No Intervention in This study
  • Serdang, Selangor, Malaysia
    Faculty of Medicine and Health Sciences
Feb 11, 2023

Group B Streptococcal Infections Trial in Ghent (GBS-NN/NN2, Placebo)

Recruiting
  • Group B Streptococcal Infections
  • GBS-NN/NN2
  • Placebo
  • Ghent, Belgium
    University Hospital Ghent - Centrum voor Vaccinologie (CEVAC) de
Mar 21, 2023

MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A

Withdrawn
  • Group B Streptococcal Infection
  • culture and PCR for group B streptococcus
  • Fayoum, Egypt
    sahar M.Y elbaradie
Mar 17, 2022

Group B Streptococcal Infection Trial in Kawempe (GBS6)

Recruiting
  • Group B Streptococcal Infection
  • Kawempe, Uganda
    Makerere University, John Hopkins University
Apr 14, 2023

IAP-EOGBSD on Offspring's Gut Microbiome and Immunity.

Active, not recruiting
  • Healthy
  • +2 more
  • Guangzhou, Guang Dong, China
    Zhujiang Hospital
Feb 12, 2023

IAP-EOGBSD on Maternal Vaginal Microbiome, Offspring's Gut

Active, not recruiting
  • Microbiome, Human
  • Guangzhou, Guang Dong, China
    Zhujiang Hospital
Feb 12, 2023

Time Frame for GBS Screening

Withdrawn
  • GBS
  • Group B Streptococcal Infection
  • genital and rectal swab
  • (no location specified)
Dec 26, 2021

Group B Streptococcal Infection Trial in Johannesburg, Kawempe (GBS-NN/NN2, Placebo)

Active, not recruiting
  • Group B Streptococcal Infection
  • GBS-NN/NN2
  • Placebo
  • Johannesburg, South Africa
  • +2 more
Aug 29, 2022

Group B Strep Infection Trial in Albuquerque (Probiotic dietary supplement)

Active, not recruiting
  • Group B Strep Infection
  • Probiotic dietary supplement
  • Albuquerque, New Mexico
    University of New Mexico Hospital
Jan 19, 2023

Group A Streptococcal Infection Trial in Edmonton (p*17-K4S2 (25 µg/mL), J8-K4S2 (100 µg/mL), p*17-K4S2 (50 µg/mL))

Not yet recruiting
  • Group A Streptococcal Infection
  • p*17-K4S2 (25 µg/mL)
  • +4 more
  • Edmonton, Alberta, Canada
    University of Alberta Hospital
Jul 26, 2022

Serosurveillance Study of Maternally Derived Anti-GBS Antibody

Unknown status
  • Group B Streptococcus Carrier in Childbirth
  • +4 more
    • Kampala, Uganda
      MUJHU Care Ltd
    Mar 17, 2021

    Group B Streptococcal Infections Trial in Stockbridge, Bardstown, Salt Lake City (Group B streptoccous 6-valent polysaccharide

    Completed
    Has Results
    • Group B Streptococcal Infections
    • Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)
    • Stockbridge, Georgia
    • +3 more
    Oct 11, 2021

    Maternal, Neonatal and Infant Outcomes at Kawempe National

    Recruiting
    • Group B Streptococcus Carrier in Childbirth
    • +4 more
      • Kampala, Uganda
        MUJHU Care Ltd
      Jan 27, 2021

      Colonization With Group B Streptococcus During Pregnancy

      Completed
      • Gestational Mother
      • Streptococcus Agalactiae Infection
        • Madrid, Spain
          Hospital Universitario La Paz
        Mar 2, 2022

        Vaginal Infection, Pregnancy Complications, Neonatal Sepsis Trial in Vienna (Astarte® (HSO Health Care GmbH, Vienna, Austria),

        Completed
        • Vaginal Infection
        • +3 more
        • Astarte® (HSO Health Care GmbH, Vienna, Austria)
        • Placebo
        • Vienna, Austria
          Medical University of Vienna, Vienna General Hospital, Departmen
        Dec 5, 2020

        Gestational Mother, Streptococcus Agalactiae Infection Trial in Madrid (Lactobacillus salivarius V4II-90, Placebo)

        Completed
        • Gestational Mother
        • Streptococcus Agalactiae Infection
        • Lactobacillus salivarius V4II-90
        • Placebo
        • Madrid, Spain
          Hospital Universitario La Paz
        Mar 2, 2022

        Group B Streptococcus Infections Trial in United States (Multivalent Group B streptococcus vaccine, Tetanus, diphtheria, and

        Not yet recruiting
        • Group B Streptococcus Infections
        • Hexavalent Group B streptococcus vaccine
        • +2 more
        • (no location specified)
        Jan 6, 2022

        Serocorrelate of Protection Against GBS

        Unknown status
        • Group B Streptococcus Carrier in Childbirth
        • +4 more
          • Paris, France
          • +5 more
          Jan 26, 2021

          Adjunctive Clindamycin Versus Linezolid for ß-lactam Treated

          Active, not recruiting
          • Streptococcal Sepsis
          • +5 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center (primary center co
          Nov 8, 2023

          Group B Streptococcus Infections Trial in South Africa, United Kingdom, United States (Multivalent Group B streptococcus

          Recruiting
          • Group B Streptococcus Infections
          • Multivalent Group B streptococcus vaccine
          • Placebo
          • Johannesburg, Gauteng, South Africa
          • +7 more
          Mar 9, 2022

          Invasive Group A Streptococcal Infection

          Recruiting
          • Sepsis Due to Streptococcus, Group A
          • +8 more
            • Créteil, France
              ACTIV
            Mar 16, 2023

            Group B Streptococcus Infection Trial in Merthyr Tydfil (GBS-NN/NN2)

            Completed
            • Group B Streptococcus Infection
            • GBS-NN/NN2
            • Merthyr Tydfil, Wales, United Kingdom
              Simbec Clinical Pharmacology
            Aug 24, 2022

            Invasive Group A Beta-Haemolytic Streptococcal Disease Trial in Alkmaar (No intervention)

            Recruiting
            • Invasive Group A Beta-Haemolytic Streptococcal Disease
            • No intervention
            • Alkmaar, NH, Netherlands
              Noordwest Ziekenhuisgroep
            Sep 21, 2023

            Development ofSerocorrelate of Protection Against Invasive Group

            Not yet recruiting
            • Streptococcus Agalactiae Infection
            • No intervention
            • London, United Kingdom
              St George's University of London
            Feb 3, 2021

            Strepic® Device for Diagnosis of Group A Streptococcal

            Completed
            • Group A Streptococcal Infection
            • Strepic® Device
            • Sylmar, California
              Olive View-UCLA Medical Center
            Apr 18, 2022